RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
  NHS
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
UK Channel

subscribe to UK newsletter
Healthcare : UK

   EMAIL   |   PRINT
National Service Framework for heart failure required

Jun 16, 2005 - 6:02:00 PM
"What is needed is recognition by central government that heart failure is common and expensive, but treatable. A National Service Framework for hear failure with specific targets is a priority,"

 
[RxPG] A new National Service Framework for chronic heart failure is urgently needed, because patients with heart failure are getting a raw deal, despite the availability of effective treatment, say leading cardiologists in Heart.

There is a wealth of reliable evidence on the appropriate treatment of heart failure and an increasing range of effective treatments, they say.

Timely treatment can roughly double life expectancy and reduce the need for repeated hospital admissions. Yet heart failure continues to be inadequately investigated and treated.

Dr Andrew Clark and Professor John Cleland of Castle Hill Hospital, in Hull, north east England, point to the evidence of a large annual European survey of 11,000 patients admitted to hospital with heart failure.

This showed that only two thirds had ever been given a heart tracing (ECG). Recommended drugs for heart failure include ACE inhibitors, beta blockers, and diuretics.

But an ACE inhibitor had not prescribed to four out of 10 patients, while a beta blocker had only been given to just over a third. And a combination of all three recommended drugs had only been prescribed to 17% of patients.

This is not just of concern to individual patients whose lives are being curtailed by lack of treatment, but also to society as a whole, warn the authors.

"Heart failure is an enormous consumer of healthcare resources. The largest proportion of these costs is on inpatient hospital care, and heart failure patients have an extremely high readmission rate," they write.

Structured management programmes, including multidisciplinary teams of nurses, pharmacists, and physiotherapists, and partnership working with patients and carers, are the way forward, say the authors.

A study from the University of East Anglia, also published in this issue, shows that multidisciplinary treatment can cut both hospital admissions and deaths from heart failure.

The current framework on coronary heart disease, while laudable in its aims, is failong patients with heart failure, say the authors.

"What is needed is recognition by central government that heart failure is common and expensive, but treatable. A National Service Framework for hear failure with specific targets is a priority," they write.

Politicians should stop prevaricating. In the end, such a move will save money, they write.



Publication: Editorial: Multidisciplinary interventions in heart failure Heart 2005; 849-50]/[Systematic review of multidisciplinary interventions in heart failure Heart 2005; 91: 899-906
On the web: www.bmj.com - read full text of the research article 

Advertise in this space for $10 per month. Contact us today.


Related UK News


Subscribe to UK Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)